Manchikanti Laxmaiah, Helm Ii Standiford, Pampati Vidyasagar, Racz Gabor B
Pain Management Center of Paducah, Paducah, KY, and University of Louisville, Louisville, KY; The Helm Center for Pain Management, Laguna Hills, CA; and Texas Tech University Health Sciences Center, Lubbock, TX.
Pain Physician. 2014 Mar-Apr;17(2):E129-39.
Multiple reviews have shown that interventional techniques for chronic pain have increased dramatically over the years. Of these interventional techniques, both sacroiliac joint injections and facet joint interventions showed explosive growth, followed by epidural procedures. Percutaneous adhesiolysis procedures have not been assessed for their utilization patterns separately from epidural injections.
An analysis of the utilization patterns of percutaneous adhesiolysis procedures in managing chronic low back pain in the Medicare population from 2000 to 2011.
To assess the utilization and growth patterns of percutaneous adhesiolysis in managing chronic low back pain.
The study was performed utilizing the Centers for Medicare and Medicaid Services (CMS) Physician Supplier Procedure Summary Master of Fee-For-Service (FFS) Data from 2000 to 2011.
Percutaneous adhesiolysis procedures increased 47% with an annual growth rate of 3.6% in the FFS Medicare population from 2000 to 2011. These growth rates are significantly lower than the growth rates for sacroiliac joint injections (331%), facet joint interventions (308%), and epidural injections (130%), but substantially lower than lumbar transforaminal injections (665%) and lumbar facet joint neurolysis (544%).
Study limitations include lack of inclusion of Medicare Advantage patients. In addition, the statewide data is based on claims which may include the contiguous or other states.
Percutaneous adhesiolysis utilization increased moderately in Medicare beneficiaries from 2000 to 2011. Overall, there was an increase of 47% in the utilization of adhesiolysis procedures per 100,000 Medicare beneficiaries, with an annual geometric average increase of 3.6%.
多项综述表明,多年来慢性疼痛的介入技术急剧增加。在这些介入技术中,骶髂关节注射和小关节干预均呈现爆发式增长,其次是硬膜外手术。经皮粘连松解术的使用模式尚未与硬膜外注射分开评估。
对2000年至2011年医疗保险人群中经皮粘连松解术治疗慢性下腰痛的使用模式进行分析。
评估经皮粘连松解术治疗慢性下腰痛的使用和增长模式。
本研究利用医疗保险和医疗补助服务中心(CMS)2000年至2011年服务收费(FFS)数据中的医师供应商程序汇总主表进行。
2000年至2011年,医疗保险服务收费(FFS)人群中经皮粘连松解术增加了47%,年增长率为3.6%。这些增长率显著低于骶髂关节注射(331%)、小关节干预(308%)和硬膜外注射(130%)的增长率,但远低于腰椎椎间孔注射(665%)和腰椎小关节神经松解术(544%)的增长率。
研究局限性包括未纳入医疗保险优势计划患者。此外,全州数据基于索赔,可能包括相邻或其他州的数据。
2000年至2011年,医疗保险受益人中经皮粘连松解术的使用适度增加。总体而言,每10万名医疗保险受益人中粘连松解术的使用增加了47%,年几何平均增长率为3.6%。